Antitrust takes ‘too long’ to deliver, says congressman

The Federal Trade Commission taking a full decade to address a drugmaker's abuse of the patent system is “unacceptable”, the head of the House of Representatives antitrust subcommittee has said.

Get unlimited access to all Global Competition Review content